These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 10348790

  • 1. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
    Möller A, Iwasaki K, Kawamura A, Teramura Y, Shiraga T, Hata T, Schäfer A, Undre NA.
    Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H, Hamrén B, Bergstrand S, Elebring M, Fryklund L, Heijer M, Ohman KP.
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
    Min DI, Chen HY, Lee MK, Ashton K, Martin MF.
    Pharmacotherapy; 1997 Sep; 17(3):457-63. PubMed ID: 9165550
    [Abstract] [Full Text] [Related]

  • 4. Disposition of [14C]avitriptan in rats and humans.
    Marathe PH, Greene DS, Barbhaiya RH.
    Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
    [Abstract] [Full Text] [Related]

  • 5. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK, Sólyom AM, Rodriguez VP, Sipes IG.
    Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
    [Abstract] [Full Text] [Related]

  • 6. Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.
    Zollinger M, Waldmeier F, Hartmann S, Zenke G, Zimmerlin AG, Glaenzel U, Baldeck JP, Schweitzer A, Berthier S, Moenius T, Grassberger MA.
    Drug Metab Dispos; 2006 May; 34(5):765-74. PubMed ID: 16467136
    [Abstract] [Full Text] [Related]

  • 7. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP, Halpin RA, Geer LA, Ellis JD, Liu L, Cheng H, Chavez-Eng C, Matuszewski BK, Varga SL, Guiblin AR, Rogers JD.
    Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
    [Abstract] [Full Text] [Related]

  • 8. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S, Shah B, Zhang J, Zeng Z, Kirkesseli S, Jensen BK.
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z, Dashti-Khavidaki S, Nasiri-Toosi M, Khalili H, Jafarian A, Irajian H, Abdollahi A, Sadrai S.
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [Abstract] [Full Text] [Related]

  • 15. Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects.
    Kovarik JM, Hartmann S, Bartlett M, Riviere GJ, Neddermann D, Wang Y, Port A, Schmouder RL.
    Biopharm Drug Dispos; 2007 Mar; 28(2):97-104. PubMed ID: 17230596
    [Abstract] [Full Text] [Related]

  • 16. The disposition and metabolism of [14C]fluconazole in humans.
    Brammer KW, Coakley AJ, Jezequel SG, Tarbit MH.
    Drug Metab Dispos; 1991 Mar; 19(4):764-7. PubMed ID: 1680653
    [Abstract] [Full Text] [Related]

  • 17. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S, Miura M, Toriumi C, Satoh Y, Ooie T.
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus pharmacokinetics in BMT patients.
    Boswell GW, Bekersky I, Fay J, Wingard J, Antin J, Weisdorf D, Maher R, Fitzsimmons W, Nash R.
    Bone Marrow Transplant; 1998 Jan; 21(1):23-8. PubMed ID: 9486490
    [Abstract] [Full Text] [Related]

  • 20. Absorption, distribution, and excretion of 14C-labeled tacrolimus (FK506) after a single or repeated ocular instillation in rabbits.
    Fujita E, Teramura Y, Mitsugi K, Ninomiya S, Iwatsubo T, Kawamura A, Kamimura H.
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):333-43. PubMed ID: 18476802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.